Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States.
about
Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cost-Effectiveness of Nivoluma ...... Melanoma in the United States.
@en
type
label
Cost-Effectiveness of Nivoluma ...... Melanoma in the United States.
@en
prefLabel
Cost-Effectiveness of Nivoluma ...... Melanoma in the United States.
@en
P2093
P2860
P1476
Cost-Effectiveness of Nivoluma ...... Melanoma in the United States.
@en
P2093
Dang M Tran
Dor Keyvani
Jay Andrew Barcelon
Leann C McDowell
Leslie Wilson
Oscar Merino
P2860
P304
P356
10.18553/JMCP.2017.23.6.653
P577
2017-06-01T00:00:00Z